ReviewCurrent pharmaceutical design2026
Gut Microbiota in the Hepato-Cardiorenal Axis: Microbial Metabolites, Inflammation, and Emerging Therapeutic Targets.
Shivam Patil et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it